Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
19.08
-0.51 (-2.60%)
At close: May 8, 2026, 4:00 PM EDT
19.10
+0.02 (0.10%)
After-hours: May 8, 2026, 6:23 PM EDT
Pulse Biosciences Revenue
Pulse Biosciences had revenue of $401.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $751.00K. In the year 2025, Pulse Biosciences had annual revenue of $350.00K.
Revenue (ttm)
$751.00K
Revenue Growth
n/a
P/S Ratio
1,733.33
Revenue / Employee
$6,474
Employees
116
Market Cap
1.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 350.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 700.00K | -718.00K | -50.63% |
| Dec 31, 2021 | 1.42M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| ICU Medical | 2.16B |
| Azenta | 596.48M |
| AtriCure | 552.16M |
| LeMaitre Vascular | 256.28M |
| STAAR Surgical Company | 239.44M |
| BioLife Solutions | 101.66M |
| Kestra Medical Technologies | 83.72M |
PLSE News
- 2 days ago - Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference - Business Wire
- 3 days ago - Pulse Biosciences Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Pulse Biosciences reports Q1 EPS (27c) vs (25c) last year - TheFly
- 6 days ago - Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results - Business Wire
- 14 days ago - Pulse Biosciences presents clinical data from nPulse Cardiac Catheter System - TheFly
- 15 days ago - Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 - Business Wire
- 20 days ago - Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting - TheFly
- 20 days ago - Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Business Wire